CDK1 and neoplasm: In tumor cells, circ-CCNB1 has been shown to bind to both CCNB1 and CDK1, thereby inhibiting the formation of the CCNB1-CDK1 complex and its entry into the nucleus, resulting in the inhibition of tumor growth and extension of mouse viability.